Survivorship: Cognitive function, Version 1.2014; Clinical practice guidelines in oncology

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 12, Issue 7, 2014, Pages 976-986

  Denlinger, Crystal S ^a   Ligibel, Jennifer A ^b   Are, Madhuri ^c   Baker, K Scott ^d   Demark Wahnefried, Wendy ^e   Friedman, Debra L ^f   Goldman, Mindy ^g   Jones, Lee ^h   King, Allison ⁱ   Ku, Grace H ^j   Kvale, Elizabeth ^e   Langbaum, Terry S ^k   Leonardi Warren, Kristin ^l   McCabe, Mary S ^h   Melisko, Michelle ^g   Montoya, Jose G ^m   Mooney, Kathi ⁿ   Morgan, Mary Ann ^o   Moslehi, Javid J ^b   O'Connor, Tracey ^p   Overholser, Linda ^l   Paskett, Electra D ^q   Raza, Muhammad ^r   Syrjala, Karen L ^d   Urba, Susan G ^s   Wakabayashi, Mark T ^t   Zee, Phyllis ^u   McMillian, Nicole R ^v   Freedman Cass, Deborah A ^v   more..

^a FOX CHASE CANCER CENTER   (United States)

^b DANA FARBER BRIGHAM AND WOMEN S CANCER CENTER   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d SEATTLE CANCER CARE ALLIANCE   (United States)

^e UNIVERSITY OF ALABAMA   (United States)

^f VANDERBILT INGRAM CANCER CENTER   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

ⁱ WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^k JOHNS HOPKINS UNIVERSITY   (United States)

^l University of Colorado Cancer Center   (United States)

^m STANFORD CANCER INSTITUTE   (United States)

ⁿ UNIVERSITY OF UTAH   (United States)

^o H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^p ROSWELL PARK CANCER INSTITUTE   (United States)

^q OHIO STATE UNIVERSITY   (United States)

^r UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^s UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^t CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^u NORTHWESTERN UNIVERSITY   (United States)

^v NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE; MODAFINIL; BENZHYDRYL DERIVATIVE; CENTRAL STIMULANT AGENT; WAKEFULNESS PROMOTING AGENT;

ARTICLE; BREAST CANCER; CANCER SURVIVOR; COGNITIVE DEFECT; COGNITIVE THERAPY; COPING BEHAVIOR; DEPRESSION; DISTRESS SYNDROME; EXERCISE; FATIGUE; HUMAN; MINI MENTAL STATE EXAMINATION; OCCUPATIONAL THERAPY; PAIN; PHARMACEUTICAL CARE; PRACTICE GUIDELINE; QUALITY OF LIFE; SLEEP DISORDER; STRESS MANAGEMENT; ADAPTIVE BEHAVIOR; ANALGESIA; BRAIN TUMOR; COGNITION DISORDERS; MORTALITY; PATHOLOGY; SLEEP DISORDERS; SURVIVAL RATE; TREATMENT OUTCOME;

ADAPTATION, PSYCHOLOGICAL; BENZHYDRYL COMPOUNDS; BRAIN NEOPLASMS; CENTRAL NERVOUS SYSTEM STIMULANTS; COGNITION DISORDERS; FATIGUE; HUMANS; METHYLPHENIDATE; OCCUPATIONAL THERAPY; PAIN MANAGEMENT; QUALITY OF LIFE; SLEEP DISORDERS; SURVIVAL RATE; TREATMENT OUTCOME; WAKEFULNESS-PROMOTING AGENTS;

EID: 84903965184     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2014.0094     Document Type: Article

References (48)

1. Janelsins MC, Kohli S, Mohile SG, et al. An update on cancer-and chemotherapy-related cognitive dysfunction: current status. Semin Oncol 2011;38:431-438.
2. Wefel JS, Schagen SB. Chemotherapy-related cognitive dysfunction. Curr Neurol Neurosci Rep 2012;12:267-275.
3. Ahles TA, Saykin AJ, McDonald BC, et al. Cognitive function in breast cancer patients prior to adjuvant treatment. Breast Cancer Res Treat 2008;110:143-152. (Pubitemid 351793851)
4. Ahles TA, Saykin AJ, McDonald BC, et al. Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. J Clin Oncol 2010;28:4434-4440.
5. Ahles TA, Root JC, Ryan EL. Cancer- and cancer treatment-associated cognitive change: an update on the state of the science. J Clin Oncol 2012;30:3675-3686.
6. Hodgson KD, Hutchinson AD, Wilson CJ, Nettelbeck T. A meta-analysis of the effects of chemotherapy on cognition in patients with cancer. Cancer Treat Rev 2012;39:297-304.
7. Phillips KM, Jim HS, Small BJ, et al. Cognitive functioning after cancer treatment: a 3-year longitudinal comparison of breast cancer survivors treated with chemotherapy or radiation and noncancer controls. Cancer 2012;118:1925-1932.
8. Wefel JS, Lenzi R, Theriault RL, et al. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer 2004;100:2292-2299. (Pubitemid 38657875)
9. Wefel JS, Lenzi R, Theriault R, et al. 'Chemobrain' in breast carcinoma?: a prologue. Cancer 2004;101:466-475.
10. Jean-Pierre P, Winters PC, Ahles TA, et al. Prevalence of self-reported memory problems in adult cancer survivors: a national cross-sectional study. J Oncol Pract 2012;8:30-34.
11. Ahles TA, Saykin AJ, Furstenberg CT, et al. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol 2002;20:485-493. (Pubitemid 34072533)
12. Anderson-Hanley C, Sherman ML, Riggs R, et al. Neuropsychological effects of treatments for adults with cancer: A meta-analysis and review of the literature. J Int Neuropsychol Soc 2003;9:967-982. (Pubitemid 37428441)
13. Deprez S, Amant F, Smeets A, et al. Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning. J Clin Oncol 2012;30:274-281.
14. Jim HS, Phillips KM, Chait S, et al. Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy. J Clin Oncol 2012;30:3578-3587.
15. Jim HS, Small B, Hartman S, et al. Clinical predictors of cognitive function in adults treated with hematopoietic cell transplantation. Cancer 2012;118:3407-3416.
16. Meadows ME, Chang G, Jones JA, et al. Predictors of neuropsychological change in patients with chronic myelogenous leukemia and myelodysplastic syndrome. Arch Clin Neuropsychol 2013;28:363-374.
17. Santini B, Talacchi A, Squintani G, et al. Cognitive outcome after awake surgery for tumors in language areas. J Neurooncol 2012;108:319-326.
18. Satoer D, Vork J, Visch-Brink E, et al. Cognitive functioning early after surgery of gliomas in eloquent areas. J Neurosurg 2012;117:831-838.
19. Scherwath A, Schirmer L, Kruse M, et al. Cognitive functioning in allogeneic hematopoietic stem cell transplantation recipients and its medical correlates: a prospective multicenter study. Psychooncology 2013;22:1509-1516.
20. Scoccianti S, Detti B, Cipressi S, et al. Changes in neurocognitive functioning and quality of life in adult patients with brain tumors treated with radiotherapy. J Neurooncol 2012;108:291-308.
21. Stewart A, Bielajew C, Collins B, et al. A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. Clin Neuropsychol 2006;20:76-89.
22. Syrjala KL, Artherholt SB, Kurland BF, et al. Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years. J Clin Oncol 2011;29:2397- 2404.
23. Vardy J, Rourke S, Tannock IF. Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research. J Clin Oncol 2007;25:2455-2463. (Pubitemid 46999217)
24. Zucchella C, Bartolo M, Di Lorenzo C, et al. Cognitive impairment in primary brain tumors outpatients: a prospective cross-sectional survey. J Neurooncol 2013;112:455-460.
25. Koppelmans V, Breteler MM, Boogerd W, et al. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy. J Clin Oncol 2012;30:1080-1086.
26. Harder H, Van Gool AR, Duivenvoorden HJ, et al. Case-referent comparison of cognitive functions in patients receiving haematopoietic stem-cell transplantation for haematological malignancies: two-year follow-up results. Eur J Cancer 2007;43:2052-2059. (Pubitemid 47380359)
27. Ganz PA, Kwan L, Castellon SA, et al. Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance. J Natl Cancer Inst 2013;105:791-801.
28. Ahles TA, Saykin AJ. Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer 2007;7:192-201.
29. Deprez S, Billiet T, Sunaert S, Leemans A. Diffusion tensor MRI of chemotherapy-induced cognitive impairment in non-CNS cancer patients: a review. Brain Imaging Behav 2013;7:409-435.
30. Simo M, Rifa-Ros X, Rodriguez-Fornells A, Bruna J. Chemobrain: a systematic review of structural and functional neuroimaging studies. Neurosci Biobehav Rev 2013;37:1311-1321.
31. Wefel JS, Saleeba AK, Buzdar AU, Meyers CA. Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer 2010;116:3348-3356.
32. Schagen SB, Das E, Vermeulen I. Information about chemotherapy-associated cognitive problems contributes to cognitive problems in cancer patients. Psychooncology 2012;21:1132-1135.
33. Nelson CJ, Nandy N, Roth AJ. Chemotherapy and cognitive deficits: mechanisms, findings, and potential interventions. Palliat Support Care 2007;5:273-280.
34. Wefel JS, Vardy J, Ahles T, Schagen SB. International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol 2011;12:703-708.
35. Vardy J, Wefel JS, Ahles T, et al. Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Ann Oncol 2008;19:623-629. (Pubitemid 351461030)
36. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
37. Ferguson RJ, McDonald BC, Rocque MA, et al. Development of CBT for chemotherapy-related cognitive change: results of a waitlist control trial. Psychooncology 2012;21:176-186.
38. Goedendorp MM, Knoop H, Gielissen MF, et al. The effects of cognitive behavioral therapy for postcancer fatigue on perceived cognitive disabilities and neuropsychological test performance. J Pain Symptom Manage 2014;47:35-44.
39. Angevaren M, Aufdemkampe G, Verhaar HJ, et al. Physical activity and enhanced fitness to improve cognitive function in older people without known cognitive impairment. Cochrane Database Syst Rev 2008:CD005381.
40. Fitzpatrick TR, Edgar L, Holcroft C. Assessing the relationship between physical fitness activities, cognitive health, and quality of life among older cancer survivors. J Psychosoc Oncol 2012;30:556-572.
41. Kramer AF, Erickson KI. Capitalizing on cortical plasticity: influence of physical activity on cognition and brain function. Trends Cogn Sci 2007;11:342-348. (Pubitemid 47077916)
42. Player L, Mackenzie L, Willis K, Loh SY. Women's experiences of cognitive changes or 'chemobrain' following treatment for breast cancer: a role for occupational therapy? [published online ahead of print February 6, 2014]. Aust Occup Ther J, doi: 10.1111/1440-1630.12113.
43. Gehring K, Roukema JA, Sitskoorn MM. Review of recent studies on interventions for cognitive deficits in patients with cancer. Expert Rev Anticancer Ther 2012;12:255-269.
44. Mar Fan HG, Clemons M, Xu W, et al. A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer. Support Care Cancer 2008;16:577-583.
45. Conklin HM, Khan RB, Reddick WE, et al. Acute neurocognitive response to methylphenidate among survivors of childhood cancer: a randomized, double-blind, cross-over trial. J Pediatr Psychol 2007;32:1127-1139. (Pubitemid 47622295)
46. Kohli S, Fisher SG, Tra Y, et al. The effect of modafinil on cognitive function in breast cancer survivors. Cancer 2009;115:2605-2616.
47. Lundorff LE, Jonsson BH, Sjogren P. Modafinil for attentional and psychomotor dysfunction in advanced cancer: a double-blind, randomised, cross-over trial. Palliat Med 2009;23:731-738.
48. Gehring K, Patwardhan SY, Collins R, et al. A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. J Neurooncol 2012;107:165-174.